These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 31770294)

  • 1. Online Direct-to-Consumer Advertising of Stem Cell Therapy for Musculoskeletal Injury and Disease: Misinformation and Violation of Ethical and Legal Advertising Parameters.
    Kingery MT; Schoof L; Strauss EJ; Bosco JA; Halbrecht J
    J Bone Joint Surg Am; 2020 Jan; 102(1):2-9. PubMed ID: 31770294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct-to-Consumer Advertising of Stem Cell Clinics: Ethical Considerations and Recommendations for the Health-Care Community.
    Pean CA; Kingery MT; Strauss E; Bosco JA; Halbrecht J
    J Bone Joint Surg Am; 2019 Oct; 101(19):e103. PubMed ID: 31577688
    [No Abstract]   [Full Text] [Related]  

  • 3. Correction of misleading information in prescription drug television advertising: The roles of advertisement similarity and time delay.
    Aikin KJ; Southwell BG; Paquin RS; Rupert DJ; O'Donoghue AC; Betts KR; Lee PK
    Res Social Adm Pharm; 2017; 13(2):378-388. PubMed ID: 27178746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct-to-Consumer Advertising for Cancer Centers and Institutes: Ethical Dilemmas and Practical Implications.
    Hlubocky FJ; McFarland DF; Spears PA; Smith L; Patten B; Peppercorn J; Holcombe R
    Am Soc Clin Oncol Educ Book; 2020 Mar; 40():1-11. PubMed ID: 32379986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulating the advertising of genetic tests in Europe: a balancing act.
    Kalokairinou L; Borry P; Howard HC
    J Med Genet; 2017 Oct; 54(10):651-656. PubMed ID: 28735297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medicine, market and communication: ethical considerations in regard to persuasive communication in direct-to-consumer genetic testing services.
    Schaper M; Schicktanz S
    BMC Med Ethics; 2018 Jun; 19(1):56. PubMed ID: 29871685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Companies inadvertently fund online misinformation despite consumer backlash.
    Ahmad W; Sen A; Eesley C; Brynjolfsson E
    Nature; 2024 Jun; 630(8015):123-131. PubMed ID: 38840014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of marketing claims by providers of stereotactic radiation therapy.
    Narang AK; Lam E; Makary MA; Deweese TL; Pawlik TM; Pronovost PJ; Herman JM
    J Oncol Pract; 2013 Jan; 9(1):57-62. PubMed ID: 23633973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The involvement of Canadian physicians in promoting and providing unproven and unapproved stem cell interventions.
    Ogbogu U; Du J; Koukio Y
    BMC Med Ethics; 2018 May; 19(1):32. PubMed ID: 29716594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing "Cell Therapy" Clinics Offering Treatments of Ocular Conditions using Direct-to-Consumer Marketing Websites in the United States.
    Nirwan RS; Albini TA; Sridhar J; Flynn HW; Kuriyan AE
    Ophthalmology; 2019 Oct; 126(10):1350-1355. PubMed ID: 30904542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on "Cell Therapy" Clinics Offering Treatments of Ocular Conditions Using Direct-To-Consumer Marketing Websites in the U.S.
    Kalavar M; Lovett EA; Nicholas MP; Ross-Hirsch A; Nirwan RS; Sridhar J; Patel S; Flynn HW; Albini TA; Kuriyan AE
    Am J Ophthalmol; 2024 Nov; 267():135-141. PubMed ID: 38880376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RECONCEPTUALIZING CONSENT FOR DIRECT-TO-CONSUMER HEALTH SERVICES.
    Spector-Bagdady K
    Am J Law Med; 2015; 41(4):568-616. PubMed ID: 26863850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The quality of Internet advertising in aesthetic surgery: an in-depth analysis.
    Wong WW; Camp MC; Camp JS; Gupta SC
    Aesthet Surg J; 2010 Sep; 30(5):735-43. PubMed ID: 20884905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease-specific direct-to-consumer advertising for reminding consumers to take medications.
    Bhutada NS; Rollins BL
    J Am Pharm Assoc (2003); 2015; 55(4):434-7. PubMed ID: 26161486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters.
    Kim H
    Int J Health Policy Manag; 2015 Aug; 4(12):813-21. PubMed ID: 26673465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct-to-physician and direct-to-consumer advertising: Time to have stringent regulations.
    Kannan S; Gowri S; Tyagi V; Kohli S; Jain R; Kapil P; Bhardwaj A
    Int J Risk Saf Med; 2015; 27(2):77-83. PubMed ID: 26410010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Tip of the Iceberg of Misleading Online Advertising Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters".
    Mintzes B
    Int J Health Policy Manag; 2016 Feb; 5(5):329-31. PubMed ID: 27239883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploiting science? A systematic analysis of complementary and alternative medicine clinic websites' marketing of stem cell therapies.
    Murdoch B; Zarzeczny A; Caulfield T
    BMJ Open; 2018 Feb; 8(2):e019414. PubMed ID: 29490963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmaceutical companies and their drugs on social media: a content analysis of drug information on popular social media sites.
    Tyrawski J; DeAndrea DC
    J Med Internet Res; 2015 Jun; 17(6):e130. PubMed ID: 26032738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Marketing of healthcare services in Denmark: the concept of misleading advertising.
    Aagaard L
    Int J Clin Pharm; 2020 Dec; 42(6):1524-1527. PubMed ID: 32789762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.